Measurement of dehydroepiandrosterone sulfate (DHEAS) in serum and cerebrospinal fluid by isotope-dilution liquid chromatography tandem mass spectrometry

Clinica Chimica Acta

Volumn 414, Issue , 2012, Pages 246-247

  Büttler, Rahel M ^a   Struys, Eduard A ^a   Addie, Ruben ^a   Blankenstein, Marinus A ^a   Heijboer, Annemieke C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

CEREBROSPINAL FLUID LEVEL; HORMONE BLOOD LEVEL; HUMAN; ISOTOPE DILUTION LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; LETTER; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MEASUREMENT ACCURACY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX HORMONE DETERMINATION; BLOOD; CEREBROSPINAL FLUID; CHEMISTRY; INDICATOR DILUTION CURVE; LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

CEREBROSPINAL FLUID; CHROMATOGRAPHY, LIQUID; DEHYDROEPIANDROSTERONE SULFATE; HUMANS; INDICATOR DILUTION TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84867634771     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.09.024     Document Type: Letter

References (12)

1. Soldin, S.J., Soldin, O.P., Steroid hormone analysis by tandem mass spectrometry. Clin Chem 55:6 (Jun 2009), 1061–1066.
2. Sulcova, J., Hill, M., Hampl, R., Starka, L., Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 154:1 (Jul 1997), 57–62.
3. Holst, J.P., Soldin, O.P., Guo, T., Soldin, S.J., Steroid hormones: relevance and measurement in the clinical laboratory. Clin Lab Med 24:1 (Mar 2004), 105–118.
4. Holst, J.P., Soldin, S.J., Tractenberg, R.E., et al. Use of steroid profiles in determining the cause of adrenal insufficiency. Steroids 72:1 (Jan 2007), 71–84.
5. Leowattana, W., DHEAS as a new diagnostic tool. Clin Chim Acta 341:1–2 (Mar 2004), 1–15.
6. Aldred, S., Mecocci, P., Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients. Arch Gerontol Geriatr 51:1 (Jul 2010), e16–e18.
7. de Bruin, V.M.S., Vieira, M.C.M., Rocha, M.N.M., Viana, G.S.B., Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia. Brain Cogn 50:2 (Nov 2002), 316–323.
8. Naylor, J.C., Hulette, C.M., Steffens, D.C., et al. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab 93:8 (Aug 2008), 3173–3178.
9. Weill-Engerer, S., David, J.P., Sazdovitch, V., et al. Neurosteroid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J Clin Endocrinol Metab 87:11 (Nov 2002), 5138–5143.
10. Kim, S.B., Hill, M., Kwak, Y.T., Hampl, R., Jo, D.H., Morfin, R., Neurosteroids: cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics. J Clin Endocrinol Metab 88:11 (Nov 2003), 5199–5206.
11. Guazzo, E.P., Kirkpatrick, P.J., Goodyer, I.M., Shiers, H.M., Herbert, J., Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab 81:11 (Nov 1996), 3951–3960.
12. Chadwick, C.A., Owen, L.J., Keevil, B.G., Development of a method for the measurement of dehydroepiandrosterone sulphate by liquid chromatography–tandem mass spectrometry. Ann Clin Biochem 42:Pt 6 (Nov 2005), 468–474.